Abstract
The aim of present study was to evaluate the stability and toxicity of different doses of liposomal melphalan in rabbit eyes and to investigate the pathological and electrophysiological changes after administration of different doses of free form of melphalan. Liposomes containing melphalan were prepared by solvent evaporation method and mean size of these liposomes and encapsulation efficacy of nanoliposomes were determined. In albino rabbits, intravitreal injections of 10, 20, and 40 µg doses of liposomal melphalan and Alkeran® as the commercial product was performed. The rabbits were euthanized at days 2, 7, 14, and 28, and the eyes were enucleated. Vitreous and aqueous samples and electrophysiological recordings were obtained before euthanization. Histological examination was performed after enucleation. Particle size of prepared liposomes was 143.6 ± 3.2 nm. Liposomes have protected melphalan completely from any undesirable release or hydrolysis for 48 h. In a histopathological study, signs of retinal toxicity were found in all doses in the liposomal group at least at one time point during the study. In melphalan injected eyes, histopathological toxicity was found in the 40 µg dose. Extensive variability was found in electrophysiological recordings, and significant waveform changes were found in all injected eyes at least on one occasion during the study. Intraocular administration of liposomal melphalan cannot prolong the drug clearance time of this drug in the vitreous humor. In the 40 µg injected eyes, significant retinal atrophic changes were detected in all eyes throughout the study, and electrophysiological results were consistent with histopathological findings.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrishami M, Zarei-Ghanavati S, Soroush D, Rouhbakhsh M, Jaafari MR, Malaekeh-Nikouei B (2009) Preparation, characterization and in vivo evaluation of nanoliposomes encapsulated bevacizuamb for intravitreal administration. Retina 29:699–703
Alexanian R, Haut A, Khan AU, Lane M, McKelvey EM, Migliore PJ, Stuckey WJ Jr, Wilson HE (1969) Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA 208:1680–1685
Bergel F, Stock JA (1953) Cytotoxic alpha amino acids and peptides. Brit Emp Cancer Campaign Ann Rept 31:6–7
Brightman K, Finlay G, Jarvis I, Knowlton T, Manktelow CT (1999) A stability-indicating method for the determination of melphalan and related impurity content by gradient HPLC. J Pharm Biom Anal 20:439–447
Buitrago E, Lagomarsino E, Mato G, Schaiquevich P (2014) Stability of melphalan solution for intravitreal injection for retinoblastoma. JAMA Ophthalmol 132:1372–1373
Ebrahim S, Peyman GA, Lee PJ (2005) Application of liposomes in ophthalmology. Surv Ophthalmol 50:167–182
Egan CM, Jones CR, McCluskey M (1981) Method for the measurement of melphalan in biological samples by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 224:338–342
Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada GL, Abramson DH (2014) Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology 121:1810–1817
Ghassemi F, Shield CL (2012) Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol 130:1268–1271
Grover S, Fishman GA, Birch DG, Locke KG, Rosner B (2003) Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology 110:1159–1163
Kirby C, Gregoriadis G (1983) The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice. Biochem Pharmacol 32:609–615
Kuznetsova NR, Stepanova EV, Peretolchina NM, Khochenkov DA, Boldyrev IA, Bovin NV, Vodovozova EL (2014) Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand. J Drug Target 22:242–250
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) International Society for Clinical Electrophysiology of Vision. ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77
Mosallaei N, Banaee T, Farzadnia M, Abedini E, Ashraf H, Malaekeh-Nikouei B (2012) Safety evaluation of nanoliposomes containing cyclosporine A after ocular administration. Curr Eye Res 37:453–456
Peyman GA, Khoobehi B, Tawakol M, Schulman JA, Mortada HA, Alkan H, Fiscella R (1987) Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model. Retina 7:227–229
Shields CL, Fulco EM, Arias JD, Alarcon C, Pellegrini M, Rishi P, Kaliki S, Bianciotto CG, Shields JA (2013) Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond) 27:253–264
Smith SJ, Smith BD (2013) Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol 97:1231–1236
Stout SA, Riley CM (1987) Hydrolysis of l-phenylalanine mustard (melphalan). II. Further observations on the effects of pH, chloride ions and buffers on the rate of reaction. Int J Pharm 31:257–264
Ueda M, Tanabe J, Inomata M, Kaneko A, Kimura T (1995) Study on conservative treatment of retinoblastoma-effect of intravitreal injection of melphalan on the rabbit retina. Nihon Ganka Gakkai Zasshi 99:1230–1235
Wasserman TH, Comis RL, Goldsmith M, Handelsman H, Penta JS, Slavik M, Soper WT, Carter SK (1975) Tabular analysis of the clinical chemotherapy of solid tumors. Cancer Chemother Rep 6:399–419
Acknowledgments
This work was supported financially by a research grant from the Vice Chancellor for Research of Mashhad University of Medical Sciences (Mashhad, Iran) and a research Grant from the Vice Chancellor for Research of Iran University of Medical Sciences (Tehran, Iran).
Declaration of Interests
Authors declare that there is no conflict of interests in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naseripour, M., Abrishami, M., Sedaghat, A. et al. Preparation and in vivo evaluation of nanoliposomes containing melphalan after intravitreal injection in albino rabbits. Journal of Pharmaceutical Investigation 46, 575–582 (2016). https://doi.org/10.1007/s40005-016-0271-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-016-0271-y